Structure-based design of peptides which inhibit IgE binding to its high affinity receptor FceRI

J. M. McDonnell, D. Fushman, A. J. Henry, J. P D Cook, G. A. Mackay, H. J. Gould, B. J. Sutton, David Cowburn

Research output: Contribution to journalArticle

Abstract

Interaction between immunoglobulin E (lgE) and its high afi:inity receptor. FceRI a-chain, is central in the development of allergic disease. One strategy for the design of therapeutics for the treatment of allergic conditions is the production of compounds which inhibit the interaction between lgl and FceRI. In this study we will describe the structure-t)ased design and development of synthetic peptide inhibitors of the IgE-FceRI a-chain interaction. We have undertaken site-directed mutagenesis of the Fc region of IgI and of FceRI a-chain and have characterized the kinetic and thermodynamic effects of these mutations. On the basis of this work we have mapped "hotspots" of binding energy for the lgE-FceRI interaction. Conformationally restricted peptides were designed to mimic one "hotspot" of binding energy comprised of a 3-hairpin loop from FceRI a-chain. Two peptide mimics of this region, one syxlthesized from L-amino acids and another as its retroenantiomer, inhibit the lgE FceRI interaction at low micromolar concentrations. The solution structures of these two peptides minlics have been solved by NMR spectroscopy and demonstrate stable 3-hairpin structure and presentation of similar topochemical surfaces. These compounds have been useful as tools for understanding the interactions between IgI-: and FceRI and may represent first generation therapeutic agents for the treatment of allergic diseases.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number9
StatePublished - 1997
Externally publishedYes

Fingerprint

Immunoglobulin E
peptides
Peptides
receptors
Binding energy
immunoglobulin E
therapeutics
synthetic peptides
site-directed mutagenesis
energy
thermodynamics
Mutagenesis
nuclear magnetic resonance spectroscopy
Site-Directed Mutagenesis
Thermodynamics
Nuclear magnetic resonance spectroscopy
mutation
kinetics
amino acids
Magnetic Resonance Spectroscopy

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

McDonnell, J. M., Fushman, D., Henry, A. J., Cook, J. P. D., Mackay, G. A., Gould, H. J., ... Cowburn, D. (1997). Structure-based design of peptides which inhibit IgE binding to its high affinity receptor FceRI. FASEB Journal, 11(9).

Structure-based design of peptides which inhibit IgE binding to its high affinity receptor FceRI. / McDonnell, J. M.; Fushman, D.; Henry, A. J.; Cook, J. P D; Mackay, G. A.; Gould, H. J.; Sutton, B. J.; Cowburn, David.

In: FASEB Journal, Vol. 11, No. 9, 1997.

Research output: Contribution to journalArticle

McDonnell, JM, Fushman, D, Henry, AJ, Cook, JPD, Mackay, GA, Gould, HJ, Sutton, BJ & Cowburn, D 1997, 'Structure-based design of peptides which inhibit IgE binding to its high affinity receptor FceRI', FASEB Journal, vol. 11, no. 9.
McDonnell JM, Fushman D, Henry AJ, Cook JPD, Mackay GA, Gould HJ et al. Structure-based design of peptides which inhibit IgE binding to its high affinity receptor FceRI. FASEB Journal. 1997;11(9).
McDonnell, J. M. ; Fushman, D. ; Henry, A. J. ; Cook, J. P D ; Mackay, G. A. ; Gould, H. J. ; Sutton, B. J. ; Cowburn, David. / Structure-based design of peptides which inhibit IgE binding to its high affinity receptor FceRI. In: FASEB Journal. 1997 ; Vol. 11, No. 9.
@article{84cd46c6ad92480cbef17e6d475e6416,
title = "Structure-based design of peptides which inhibit IgE binding to its high affinity receptor FceRI",
abstract = "Interaction between immunoglobulin E (lgE) and its high afi:inity receptor. FceRI a-chain, is central in the development of allergic disease. One strategy for the design of therapeutics for the treatment of allergic conditions is the production of compounds which inhibit the interaction between lgl and FceRI. In this study we will describe the structure-t)ased design and development of synthetic peptide inhibitors of the IgE-FceRI a-chain interaction. We have undertaken site-directed mutagenesis of the Fc region of IgI and of FceRI a-chain and have characterized the kinetic and thermodynamic effects of these mutations. On the basis of this work we have mapped {"}hotspots{"} of binding energy for the lgE-FceRI interaction. Conformationally restricted peptides were designed to mimic one {"}hotspot{"} of binding energy comprised of a 3-hairpin loop from FceRI a-chain. Two peptide mimics of this region, one syxlthesized from L-amino acids and another as its retroenantiomer, inhibit the lgE FceRI interaction at low micromolar concentrations. The solution structures of these two peptides minlics have been solved by NMR spectroscopy and demonstrate stable 3-hairpin structure and presentation of similar topochemical surfaces. These compounds have been useful as tools for understanding the interactions between IgI-: and FceRI and may represent first generation therapeutic agents for the treatment of allergic diseases.",
author = "McDonnell, {J. M.} and D. Fushman and Henry, {A. J.} and Cook, {J. P D} and Mackay, {G. A.} and Gould, {H. J.} and Sutton, {B. J.} and David Cowburn",
year = "1997",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "9",

}

TY - JOUR

T1 - Structure-based design of peptides which inhibit IgE binding to its high affinity receptor FceRI

AU - McDonnell, J. M.

AU - Fushman, D.

AU - Henry, A. J.

AU - Cook, J. P D

AU - Mackay, G. A.

AU - Gould, H. J.

AU - Sutton, B. J.

AU - Cowburn, David

PY - 1997

Y1 - 1997

N2 - Interaction between immunoglobulin E (lgE) and its high afi:inity receptor. FceRI a-chain, is central in the development of allergic disease. One strategy for the design of therapeutics for the treatment of allergic conditions is the production of compounds which inhibit the interaction between lgl and FceRI. In this study we will describe the structure-t)ased design and development of synthetic peptide inhibitors of the IgE-FceRI a-chain interaction. We have undertaken site-directed mutagenesis of the Fc region of IgI and of FceRI a-chain and have characterized the kinetic and thermodynamic effects of these mutations. On the basis of this work we have mapped "hotspots" of binding energy for the lgE-FceRI interaction. Conformationally restricted peptides were designed to mimic one "hotspot" of binding energy comprised of a 3-hairpin loop from FceRI a-chain. Two peptide mimics of this region, one syxlthesized from L-amino acids and another as its retroenantiomer, inhibit the lgE FceRI interaction at low micromolar concentrations. The solution structures of these two peptides minlics have been solved by NMR spectroscopy and demonstrate stable 3-hairpin structure and presentation of similar topochemical surfaces. These compounds have been useful as tools for understanding the interactions between IgI-: and FceRI and may represent first generation therapeutic agents for the treatment of allergic diseases.

AB - Interaction between immunoglobulin E (lgE) and its high afi:inity receptor. FceRI a-chain, is central in the development of allergic disease. One strategy for the design of therapeutics for the treatment of allergic conditions is the production of compounds which inhibit the interaction between lgl and FceRI. In this study we will describe the structure-t)ased design and development of synthetic peptide inhibitors of the IgE-FceRI a-chain interaction. We have undertaken site-directed mutagenesis of the Fc region of IgI and of FceRI a-chain and have characterized the kinetic and thermodynamic effects of these mutations. On the basis of this work we have mapped "hotspots" of binding energy for the lgE-FceRI interaction. Conformationally restricted peptides were designed to mimic one "hotspot" of binding energy comprised of a 3-hairpin loop from FceRI a-chain. Two peptide mimics of this region, one syxlthesized from L-amino acids and another as its retroenantiomer, inhibit the lgE FceRI interaction at low micromolar concentrations. The solution structures of these two peptides minlics have been solved by NMR spectroscopy and demonstrate stable 3-hairpin structure and presentation of similar topochemical surfaces. These compounds have been useful as tools for understanding the interactions between IgI-: and FceRI and may represent first generation therapeutic agents for the treatment of allergic diseases.

UR - http://www.scopus.com/inward/record.url?scp=33750226312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750226312&partnerID=8YFLogxK

M3 - Article

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 9

ER -